AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20187454 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional simple sacral laminectomies with resection of the cysts (group A, 25 cases)
Number of subjects: 55
Study 20187454 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐guided percutaneous fibrin glue therapy of arachnoid cysts (group B, 30 cases)
Number of subjects: 55
Study 20187454 — intervention group
Group type: COMPARATOR
Intervention: Comparison between group A and group B
Number of subjects: 55
Study 17512795 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term oxygen administration for more than 3 months
Number of subjects: 48
Study 17512795 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term oxygen administration for 2 weeks
Number of subjects: 48
Study 17512795 — intervention group
Group type: COMPARATOR
Intervention: Untreated OSAS patients
Number of subjects: 48
Study 16138333 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course high-dose methylprednisolone (HDMP) at a daily dose of 30 mg/kg starting 4 days before consolidation therapy
Number of subjects: 34
Study 16138333 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course high-dose methylprednisolone (HDMP)
Number of subjects: 34
Study 16138333 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HDMP)
Number of subjects: 34
Study 12202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (0.8 mg)
Number of subjects: 34
Study 12202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (0.8 mg)
Number of subjects: 34
Study 12202418 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol continued for an additional 7 days
Number of subjects: 34
Study 10207682 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee angular velocity of 60 degrees.s‐1
Number of subjects: 11
Study 10207682 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee angular velocity of 180 degrees.s‐1
Number of subjects: 11
Study 10207682 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee angular velocity of 120 degrees.s‐1
Number of subjects: 11
Study 7791814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with cyclosporine (2.5 to 5 mg per kilogram of body weight per day) and methotrexate (at the maximal tolerated dose)
Number of subjects: 148
Study 7791814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with cyclosporine and methotrexate
Number of subjects: 148
Study 2350206 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 16
Study 2350206 — intervention group
Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 16
Study 359085 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy with pyloroplasty
Number of subjects: 64
Study 359085 — intervention group
Group type: COMPARATOR
Intervention: Proximal gastric vagotomy without pyloroplasty
Number of subjects: 64
Study 30531419 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression socks (COMP, n = 6)
Number of subjects: 12
Study 30531419 — intervention group
Group type: COMPARATOR
Intervention: Passive control (CON, n = 6)
Number of subjects: 12
Study 28683016 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR) technique
Number of subjects: 60
Study 28683016 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PMR technique)
Number of subjects: 60
Study 27004301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₂ (20,000 IU weekly)
Number of subjects: 47
Study 27004301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₃ (15,000 IU weekly)
Number of subjects: 47
Study 27004301 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 27004301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (D₂ or D₃)
Number of subjects: 47
Study 27004301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₂ vs Vitamin D₃
Number of subjects: 47
Study 24195210 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment combined with semiconductor laser irradiation
Number of subjects: 30
Study 22061038 — intervention group
Group type: EXPERIMENTAL
Intervention: PCP motivational interview + CATCH‐IT Internet program (MI)
Number of subjects: 84
Study 22061038 — intervention group
Group type: COMPARATOR
Intervention: PCP brief advice + CATCH‐IT Internet program (BA)
Number of subjects: 84
Study 19560764 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-guidewire technique (DGT)
Number of subjects: 188
Study 19560764 — intervention group
Group type: COMPARATOR
Intervention: Standard cannulation technique (SCT)
Number of subjects: 188
Study 17026508 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension side
Number of subjects: 18
Study 17026508 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression side
Number of subjects: 18
Study 17026508 — intervention group
Group type: COMPARATOR
Intervention: Control teeth
Number of subjects: 18
Study 12594313 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental therapy with doxorubicin, vincristine, cyclophosphamide, dactinomycin, alternating with ifosfamide and etoposide
Number of subjects: 518
Study 12594313 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy with doxorubicin, vincristine, cyclophosphamide, and dactinomycin
Number of subjects: 518
Study 10225164 — intervention group
Group type: EXPERIMENTAL
Intervention: Study Group (SG) - received a list of seven questions before the preoperative interview.
Number of subjects: 125
Study 10225164 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - did not receive any suggested questions.
Number of subjects: 125
Study 10225164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SG and CG)
Number of subjects: 125
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotics
Number of subjects: 75
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Single joint puncture
Number of subjects: 75
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple puncture and intraarticular antibiotic therapy
Number of subjects: 75
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrotomy and drainage of the joint
Number of subjects: 75
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrotomy from antero-lateral approach, suction drainage for 24-48 hours, systemic intravenous antibiotic therapy, abduction position of extremity in Frejka pillow and early physiotherapy
Number of subjects: 75
Study 9102242 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic results according to Hunk classification
Number of subjects: 75
Study 1992877 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated ESR (greater than 30 mm/h) after therapy
Number of subjects: 772
Study 1992877 — intervention group
Group type: EXPERIMENTAL
Intervention: Early relapse
Number of subjects: 772
Study 1992877 — intervention group
Group type: EXPERIMENTAL
Intervention: ESR patterns 4, 5, and 6
Number of subjects: 772
Study 1992877 — intervention group
Group type: COMPARATOR
Intervention: Modern radiotherapy
Number of subjects: 772
Study 6337624 — intervention group
Group type: EXPERIMENTAL
Intervention: Grating stimulation (CAM therapy)
Number of subjects: 38
Study 6337624 — intervention group
Group type: COMPARATOR
Intervention: Full-time occlusion
Number of subjects: 38
Study 6337624 — intervention group
Group type: EXPERIMENTAL
Intervention: Grating stimulation
Number of subjects: 38
Study 29769167 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 7213
Study 29769167 — intervention group
Group type: COMPARATOR
Intervention: Post-PCI bivalirudin infusion
Number of subjects: 7213
Study 29578595 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity group (2 group sessions, laboratory report of baseline smoke exposure, 3 follow-up calls over 6 months)
Number of subjects: 203
Study 29578595 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief-intensity group (1 group session on tobacco-cessation resources)
Number of subjects: 203
Study 26599371 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on relatively good trials
Number of subjects: 0
Study 26599371 — intervention group
Group type: COMPARATOR
Intervention: Feedback on relatively poor trials
Number of subjects: 0
Study 26599371 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of feedback manipulation (aware group)
Number of subjects: 0
Study 26599371 — intervention group
Group type: COMPARATOR
Intervention: Unawareness of feedback manipulation (unaware group)
Number of subjects: 0
Study 24481333 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix(2) polyglycolic/polylactic acid biopolymer‐modified coils
Number of subjects: 626
Study 24481333 — intervention group
Group type: COMPARATOR
Intervention: Bare metal coils
Number of subjects: 626
Study 22617130 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1+paclitaxel
Number of subjects: 83
Study 22617130 — intervention group
Group type: COMPARATOR
Intervention: S‐1+cisplatin
Number of subjects: 83
Study 19095215 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by axillary lymph node dissection (ALND)
Number of subjects: 191
Study 19095215 — intervention group
Group type: COMPARATOR
Intervention: Primary axillary lymph node dissection (ALND) after positive sentinel node biopsy
Number of subjects: 191
Study 17239076 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling program performed two days per week, each session lasting one hour.
Number of subjects: 62
Study 17239076 — intervention group
Group type: COMPARATOR
Intervention: No counselling (control group).
Number of subjects: 62
Study 16239941 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 114850
Study 16239941 — intervention group
Group type: EXPERIMENTAL
Intervention: Journal articles
Number of subjects: 114850
Study 16239941 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicenter studies
Number of subjects: 114850
Study 16239941 — intervention group
Group type: EXPERIMENTAL
Intervention: English language publications
Number of subjects: 114850
Study 16239941 — intervention group
Group type: EXPERIMENTAL
Intervention: Core journals identified
Number of subjects: 114850
Study 12139535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 150 mg
Number of subjects: 45
Study 12139535 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine 150 mg
Number of subjects: 45
Study 12139535 — intervention group
Group type: COMPARATOR
Intervention: Plain bupivacaine 15 mg
Number of subjects: 45
Study 12139535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine
Number of subjects: 45
Study 12139535 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine
Number of subjects: 45
Study 12139535 — intervention group
Group type: COMPARATOR
Intervention: Plain bupivacaine
Number of subjects: 45
Study 10340983 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 36
Study 10340983 — intervention group
Group type: COMPARATOR
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 36
Study 7787819 — intervention group
Group type: EXPERIMENTAL
Intervention: Air pollution exposure (measured through outdoor air contaminants including nitrogen oxides and sulphur dioxide)
Number of subjects: 0
Study 7787819 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported symptoms from upper and lower respiratory tract and general symptoms of ill health
Number of subjects: 0
Study 2522919 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion SR 2508 (etanidazole)
Number of subjects: 21
Study 332100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fructose treatment
Number of subjects: 0
Study 332100 — intervention group
Group type: COMPARATOR
Intervention: Glucose (control)
Number of subjects: 0
Study 31937347 — intervention group
Group type: EXPERIMENTAL
Intervention: Ronopterin (48-hour intravenous infusion starting at 6 to 18 hours after injury)
Number of subjects: 0
Study 31937347 — intervention group
Group type: COMPARATOR
Intervention: Placebo (48-hour intravenous infusion starting at 6 to 18 hours after injury)
Number of subjects: 0
Study 31937347 — intervention group
Group type: EXPERIMENTAL
Intervention: Ronopterin
Number of subjects: 0
Study 31937347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31281056 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraretinal hypereflective foci (IHRF)
Number of subjects: 501
Study 31281056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyporeflective foci (hRF) within drusenoid lesions (DLs)
Number of subjects: 501
Study 31281056 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal drusenoid deposits (SDD)
Number of subjects: 501
Study 31281056 — intervention group
Group type: EXPERIMENTAL
Intervention: Drusen volume (DV) of 0.03 mm3 or more
Number of subjects: 501
Study 31281056 — intervention group
Group type: EXPERIMENTAL
Intervention: Late AMD (defined as MNV, complete retinal pigment epithelium and photoreceptor atrophy [cRORA], or both)
Number of subjects: 501
Study 28011155 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept or adalimumab combined with methotrexate
Number of subjects: 48
Study 25671770 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (80, 100, or 120 mg day‐1 for 1 year)
Number of subjects: 505
Study 25671770 — intervention group
Group type: COMPARATOR
Intervention: UFT (300 or 400 mg day‐1 for 1 year)
Number of subjects: 505
Study 25671770 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 505
Study 25671770 — intervention group
Group type: COMPARATOR
Intervention: UFT
Number of subjects: 505
Study 23721752 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including an initial interactive workshop and quarterly educational outreach visits focused on maternal death reviews and best practices implementation over 2 years.
Number of subjects: 191167
Study 23721752 — intervention group
Group type: COMPARATOR
Intervention: Control group with no external intervention.
Number of subjects: 191167
Study 21350053 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI <23.5 kg/m(2)
Number of subjects: 4109
Study 21350053 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥35 kg/m(2)
Number of subjects: 4109
Study 21350053 — intervention group
Group type: COMPARATOR
Intervention: BMI 26.5 to 30.9 kg/m(2)
Number of subjects: 4109
Study 21350053 — intervention group
Group type: EXPERIMENTAL
Intervention: All BMI categories
Number of subjects: 4109
Study 19300388 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy group (2 g of soybeans per kilogram body weight for 7 days)
Number of subjects: 36
Study 19300388 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet)
Number of subjects: 36
Study 17126434 — intervention group
Group type: EXPERIMENTAL
Intervention: 16Gy boost radiation after 50Gy whole breast irradiation
Number of subjects: 5318
Study 17126434 — intervention group
Group type: COMPARATOR
Intervention: No boost radiation after 50Gy whole breast irradiation
Number of subjects: 5318
Study 15557666 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-component acellular pertussis vaccine
Number of subjects: 0
Study 11710749 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive ratio schedule
Number of subjects: 8
Study 11710749 — intervention group
Group type: COMPARATOR
Intervention: Random sequences of ratio requirements
Number of subjects: 8
Study 9151915 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI)
Number of subjects: 415
Study 9151915 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX)
Number of subjects: 415
Study 9151915 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (DOX) low-risk subgroup
Number of subjects: 415
Study 9151915 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) high-risk subgroup
Number of subjects: 415
Study 9151915 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) and Doxorubicin (DOX)
Number of subjects: 415
Study 7899837 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac alone
Number of subjects: 0
Study 7899837 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac and methylprednisolone
Number of subjects: 0
Study 7899837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2776141 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan 100 mg orally once daily for 3 days
Number of subjects: 12
Study 164510 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 percent papaverine cream
Number of subjects: 45
Study 164510 — intervention group
Group type: COMPARATOR
Intervention: cream alone
Number of subjects: 45
Study 30346850 — intervention group
Group type: EXPERIMENTAL
Intervention: RBAC (3 grams/day for 6 months)
Number of subjects: 47
Study 30346850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 31604081 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care centers (ICCs) delivering HIV testing and HCV testing/education
Number of subjects: 11993
Study 31604081 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 11993
Study 31146493 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowly digestible carbohydrate (SDC) in water
Number of subjects: 14
Study 31146493 — intervention group
Group type: EXPERIMENTAL
Intervention: SDC drink-mix powder reconstituted in skim milk
Number of subjects: 14
Study 31146493 — intervention group
Group type: COMPARATOR
Intervention: Dextrose in water (placebo)
Number of subjects: 14
Study 31146493 — intervention group
Group type: COMPARATOR
Intervention: Control drink-mix reconstituted in skim milk (without SDC)
Number of subjects: 14
Study 27356547 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation (50 µg)
Number of subjects: 183
Study 27356547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 27356547 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal total homocysteine (tHcy) levels
Number of subjects: 183
Study 24785136 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored educational intervention for 6 weeks (90 minutes once a week)
Number of subjects: 60
Study 24785136 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study 23084254 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised multimodal exercise intervention (9 hours weekly for 6 weeks)
Number of subjects: 213
Study 23084254 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised multimodal exercise intervention
Number of subjects: 213
Study 23084254 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 213
Study 21288350 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit (GF) preload
Number of subjects: 85
Study 21288350 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) preload
Number of subjects: 85
Study 21288350 — intervention group
Group type: COMPARATOR
Intervention: Water preload
Number of subjects: 85
Study 21288350 — intervention group
Group type: EXPERIMENTAL
Intervention: All preloads combined with caloric restriction
Number of subjects: 85
Study 18849016 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) withdrawal
Number of subjects: 66
Study 18849016 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein concentration of 20 mg/L or greater
Number of subjects: 66
Study 18849016 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin level less than 12 g/dL
Number of subjects: 66
Study 18849016 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil count 4 x 10(9)/L or greater
Number of subjects: 66
Study 22240283 — intervention group
Group type: EXPERIMENTAL
Intervention: Conatumumab-doxorubicin (doxorubicin 75 mg/m2 + conatumumab 15 mg/kg every 3 weeks)
Number of subjects: 128
Study 22240283 — intervention group
Group type: COMPARATOR
Intervention: Placebo-doxorubicin (doxorubicin 75 mg/m2 + placebo)
Number of subjects: 128
Study 16040577 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0
Study 16040577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12423518 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration platelets (HCPs) stored for 1 day
Number of subjects: 9
Study 12423518 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration platelets (HCPs) stored for 2 days
Number of subjects: 9
Study 12423518 — intervention group
Group type: EXPERIMENTAL
Intervention: High-concentration platelets (HCPs) stored for 5 days
Number of subjects: 9
Study 12423518 — intervention group
Group type: COMPARATOR
Intervention: Standard apheresis platelets (APCs)
Number of subjects: 9
Study 9796223 — intervention group
Group type: EXPERIMENTAL
Intervention: Different neighboring concepts linked to the test cue
Number of subjects: 0
Study 9796223 — intervention group
Group type: EXPERIMENTAL
Intervention: Different kinds of cues (taxonomic category names, ending sounds, meaningfully related associates)
Number of subjects: 0
Study 8584362 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 111
Study 8584362 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 111
Study 8584362 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 111
Study 8584362 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment failure
Number of subjects: 111
Study 8584362 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical failure
Number of subjects: 111
Study 8584362 — intervention group
Group type: EXPERIMENTAL
Intervention: Children who failed treatment
Number of subjects: 111
Study 2128949 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg lithium carbonate
Number of subjects: 9
Study 2128949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2128949 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 9
Study 652005 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor blood containing high titer of anti-HBc but lacking HBsAg and anti-HBs; 4 patients received this blood.
Number of subjects: 30
Study 652005 — intervention group
Group type: COMPARATOR
Intervention: Control group (26 patients); no exposure to high titer anti-HBc blood.
Number of subjects: 30
Study 652005 — intervention group
Group type: COMPARATOR
Intervention: Patients with 'immunization-like' response (9 patients); developed anti-HBs without anti-HBc.
Number of subjects: 30